RIFAXIMIN PLUS LACTULOSE IS MORE EFFICACIOUS THAN LACTULOSE ALONE FOR THE PREVENTION OF OVERT HEPATIC ENCEPHALOPATHY (OHE) IN PATIENTS WITH OR WITHOUT ASCITES

被引：0
|
作者：
Kowdley, Kris V.
Reau, Nancy
Pyrsopoulos, Nikolaos T.
Allen, Christopher
Heimanson, Zeev
Sanyal, Arun J.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1548
引用
收藏
页码：S1327 / S1327
页数：1
相关论文
共 50 条
  • [41] Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed
    Maharshi, Sudhir
    Sharma, Barjesh Chander
    Srivastava, Siddharth
    Jindal, Amit
    GUT, 2015, 64 (08) : 1341 - +
  • [42] Outcomes of lactulose plus branched-chain amino acid infusion and lactulose alone for hepatic encephalopathy: A retrospective cohort study using a national inpatient database
    Okada, Akira
    Yamana, Hayato
    Yamaguchi, Satoko
    Kurakawa, Kayo Ikeda
    Matsui, Hiroki
    Fushimi, Kiyohide
    Nangaku, Masaomi
    Kadowaki, Takashi
    Yasunaga, Hideo
    HEPATOLOGY RESEARCH, 2020, 50 (06) : 693 - 703
  • [43] Impact of Rifaximin Use on Overt Hepatic Encephalopathy (OHE) Rehospitalizations Post-Discharge From an OHE Hospitalization in Commercially and Medicare-Insured Patients
    Jesudian, Arun B.
    Gagnon-Sanschagrin, Patrick
    Bungay, Rebecca
    Easson, Kaitlyn
    Shah, Aditi
    Guerin, Annie
    Samson, Aaron
    Olujohungbe, Olamide
    Bumpass, Brock
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1240 - S1241
  • [44] AN EXPLORATORY ANALYSIS OF THE SURVIVAL BENEFITS IN COMMERCIALLY INSURED PATIENTS WITH HEPATIC ENCEPHALOPATHY (HE) TREATED WITH RIFAXIMIN VERSUS LACTULOSE ALONE USING US CLAIMS DATA
    Burne, R.
    Volk, M. L.
    Guerin, A.
    Shi, S.
    Joseph, G.
    Heimanson, Z.
    Ahmad, M.
    VALUE IN HEALTH, 2021, 24 : S95 - S96
  • [45] Cost-Effectiveness of Rifaximin/alpha versus Lactulose in preventing recurrent episodes of overt hepatic encephalopathy: a systematic review and meta-analysis
    Siddiqui, Kashif
    Attri, Sumeet
    Olando, Massimo
    Lelli, Filippo
    Maida, Valeria
    Thabut, Dominique
    JOURNAL OF HEPATOLOGY, 2021, 75 : S356 - S357
  • [46] Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy
    Schulz, Christian
    Schuette, Kerstin
    Vilchez-Vargas, Ramiro
    Vasapolli, Riccardo
    Malfertheiner, Peter
    DIGESTIVE DISEASES, 2019, 37 (02) : 161 - 169
  • [47] Comparison of the Effectiveness and Safety Profile of Polyethylene Glycol-Electrolyte Solution with Lactulose in patients of Overt Hepatic Encephalopathy
    Bajwa, Khalid Nawaz
    Aziz, Bilal
    Nazar, Tazeen
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (02): : 411 - 414
  • [48] PATIENTS WITH CIRRHOSIS AND A HISTORY OF OVERT HEPATIC ENCEPHALOPATHY EXPERIENCED LOWER 6-MONTH ALL-CAUSE MORTALITY RATES WITH RIFAXIMIN MONOTHERAPY VERSUS LACTULOSE MONOTHERAPY
    Bajaj, Jasmohan
    Rahimi, Robert
    Allen, Christopher
    Heimanson, Zeev
    Israel, Robert
    Kowdley, Kris
    HEPATOLOGY, 2024, 80 : S1711 - S1711
  • [49] MELD BASED COMPARISON OF HOSPITALIZATIONS FROM HEPATIC ENCEPHALOPATHY IN PATIENTS WITH ADVANCED LIVER DISEASE ON RIFAXIMIN AND LACTULOSE COMBINATION THERAPY
    Hassett, Molly
    Ramireddy, Silpa
    Mantry, Parvez S.
    HEPATOLOGY, 2011, 54 : 1263A - 1264A
  • [50] A crossover retrospective chart review evaluating hospitalizations associated with the use of rifaximin vs lactulose in the management of patients with hepatic encephalopathy
    Leevy, CB
    Phillips, JA
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S134 - S134
12345